9 Analysts Assess Colgate-Palmolive: What You Need To Know
Portfolio Pulse from Benzinga Insights
Recent analyst ratings for Colgate-Palmolive (NYSE:CL) show a generally positive outlook, with upgrades and raised price targets reflecting optimism about the company's performance and market position. The average 12-month price target is $91.33, indicating a 6.56% increase from the previous average of $85.71. Colgate-Palmolive's financial indicators such as revenue growth, net margin, ROE, and ROA are strong, although its high debt-to-equity ratio poses a challenge. The company's global presence and diverse product range contribute to its robust market capitalization and investor confidence.
April 10, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Colgate-Palmolive has received positive analyst ratings, with several upgrades and an increased average price target of $91.33. Financial indicators show strong performance, but a high debt-to-equity ratio is noted as a potential concern.
The positive analyst ratings and raised price targets suggest confidence in Colgate-Palmolive's market position and future performance, likely leading to a short-term positive impact on its stock price. The company's strong financial indicators such as revenue growth, net margin, ROE, and ROA further support this outlook, although the high debt-to-equity ratio is a concern that investors should monitor. Overall, the predominance of bullish sentiments among analysts, coupled with the company's solid financial health, suggests a favorable short-term outlook for CL's stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100